Literature DB >> 34661701

Prognostic Impact of Indicators of Systemic Inflammation and the Nutritional Status of Patients with Resected Carcinoma of the Ampulla of Vater: A Single-Center Retrospective Study.

Yuji Shimizu1, Ryo Ashida2, Teiichi Sugiura1, Yukiyasu Okamura1, Takaaki Ito1, Yusuke Yamamoto1, Katsuhisa Ohgi1, Shimpei Otsuka1, Akifumi Notsu3, Katsuhiko Uesaka1.   

Abstract

BACKGROUND: Several indicators of systemic inflammation and nutritional status were recently shown to serve as novel prognostic factors for certain cancers. Here, we aimed to investigate the prognostic impact of preoperative indicators of systemic inflammation and nutritional status associated with the survival of patients with resected ampulla of Vater carcinoma (AC).
METHODS: We retrospectively analyzed the records of 91 patients who underwent pancreatoduodenectomy (PD) for AC from January 2002 through December 2018. Indices for systemic inflammation and nutritional status (Systemic immune-inflammation index [SII], Prognostic nutritional index [PNI], modified Glasgow prognostic score [mGPS], and Controlling nutritional status score [CONUT]) were determined using preoperative blood tests. Clinicopathological factors and these indices were analyzed to identify predictors of overall survival (OS).
RESULTS: The median preoperative SII and PNI values were 456.7 and 47.5, respectively, and their optimal cut-off values were 670.0 and 50.0, respectively. Univariate analysis revealed that high SII, low PNI, mGPS ≥ 1, and malnutrition, assessed using the CONUT, were significant predictors of shorter OS. Multivariate analysis revealed that high SII (HR = 2.71, p = 0.023) and malnutrition assessed using the CONUT (hazard ratio = 3.98, p = 0.006) were independent predictors of shorter OS.
CONCLUSION: SII and the CONUT predicted the survival of patients with AC after radical resection. These indicators are easily calculated using preoperative blood tests and may contribute to the development of improved strategies to treat AC.
© 2021. Société Internationale de Chirurgie.

Entities:  

Mesh:

Year:  2021        PMID: 34661701     DOI: 10.1007/s00268-021-06346-3

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  69 in total

1.  Systemic immune-inflammation index predicts prognosis of patients after curative resection for hepatocellular carcinoma.

Authors:  Bo Hu; Xin-Rong Yang; Yang Xu; Yun-Fan Sun; Chao Sun; Wei Guo; Xin Zhang; Wei-Min Wang; Shuang-Jian Qiu; Jian Zhou; Jia Fan
Journal:  Clin Cancer Res       Date:  2014-09-30       Impact factor: 12.531

2.  Carcinoma of the ampulla of Vater: patterns of failure following resection and benefit of chemoradiotherapy.

Authors:  Manisha Palta; Pretesh Patel; Gloria Broadwater; Christopher Willett; Joseph Pepek; Douglas Tyler; S Yousuf Zafar; Hope Uronis; Herbert Hurwitz; Rebekah White; Brian Czito
Journal:  Ann Surg Oncol       Date:  2011-11-02       Impact factor: 5.344

3.  Can Neutrophil-to-Lymphocyte Ratio, Monocyte-to-Lymphocyte Ratio, and Platelet-to-Lymphocyte Ratio at Day +100 be used as a prognostic marker in Multiple Myeloma patients with autologous transplantation?

Authors:  Serife Solmaz Medeni; Celal Acar; Aybuke Olgun; Alev Acar; Ahmet Seyhanlı; Emin Taskıran; Omur Gokmen Sevindik; Inci Alacacıoglu; Ozden Piskin; Mehmet Ali Ozcan; Fatih Demirkan; Bulent Undar; Guner Hayri Ozsan
Journal:  Clin Transplant       Date:  2018-08-26       Impact factor: 2.863

4.  Prognostic Significance of Preoperative Controlling Nutritional Status (CONUT) Score in Patients Undergoing Hepatic Resection for Hepatocellular Carcinoma.

Authors:  Norifumi Harimoto; Tomoharu Yoshizumi; Kazuhito Sakata; Akihisa Nagatsu; Takashi Motomura; Shinji Itoh; Noboru Harada; Toru Ikegami; Hideaki Uchiyama; Yuji Soejima; Yoshihiko Maehara
Journal:  World J Surg       Date:  2017-11       Impact factor: 3.352

5.  Resected periampullary adenocarcinoma: 5-year survivors and their 6- to 10-year follow-up.

Authors:  Taylor S Riall; John L Cameron; Keith D Lillemoe; Jordan M Winter; Kurtis A Campbell; Ralph H Hruban; David Chang; Charles J Yeo
Journal:  Surgery       Date:  2006-08-28       Impact factor: 3.982

6.  Patterns and predictors of failure after curative resections of carcinoma of the ampulla of Vater.

Authors:  Takeshi Todoroki; Naoto Koike; Yukio Morishita; Toru Kawamoto; Nobuhiro Ohkohchi; Junichi Shoda; Yoshiharu Fukuda; Hideto Takahashi
Journal:  Ann Surg Oncol       Date:  2003-12       Impact factor: 5.344

7.  Prognosis of patients with colorectal cancer is associated with lymph node ratio: a single-center analysis of 3,026 patients over a 25-year time period.

Authors:  Robert Rosenberg; Jan Friederichs; Tibor Schuster; Ralf Gertler; Matthias Maak; Karen Becker; Anne Grebner; Kurt Ulm; Heinz Höfler; Hjalmar Nekarda; Jörg-Rüdiger Siewert
Journal:  Ann Surg       Date:  2008-12       Impact factor: 12.969

8.  Systemic immune-inflammation index (SII) is useful to predict survival outcomes in patients with surgically resected esophageal squamous cell carcinoma.

Authors:  Yibo Gao; Wei Guo; Songhua Cai; Fan Zhang; Fei Shao; Guochao Zhang; Tiejun Liu; Fengwei Tan; Ning Li; Qi Xue; Shugeng Gao; Jie He
Journal:  J Cancer       Date:  2019-06-02       Impact factor: 4.207

9.  Systemic Immune-Inflammation Index (SII) Predicts Poor Survival in Pancreatic Cancer Patients Undergoing Resection.

Authors:  Gerd Jomrich; Elisabeth S Gruber; Daniel Winkler; Marlene Hollenstein; Michael Gnant; Klaus Sahora; Martin Schindl
Journal:  J Gastrointest Surg       Date:  2019-03-28       Impact factor: 3.452

10.  Systemic immune-inflammation index for predicting prognosis of colorectal cancer.

Authors:  Jian-Hui Chen; Er-Tao Zhai; Yu-Jie Yuan; Kai-Ming Wu; Jian-Bo Xu; Jian-Jun Peng; Chuang-Qi Chen; Yu-Long He; Shi-Rong Cai
Journal:  World J Gastroenterol       Date:  2017-09-14       Impact factor: 5.742

View more
  1 in total

1.  Early Recurrence in Resected Gallbladder Carcinoma: Clinical Impact and Its Preoperative Predictive Score.

Authors:  Yuji Shimizu; Ryo Ashida; Teiichi Sugiura; Yukiyasu Okamura; Katsuhisa Ohgi; Mihoko Yamada; Shimpei Otsuka; Takeshi Aramaki; Akifumi Notsu; Katsuhiko Uesaka
Journal:  Ann Surg Oncol       Date:  2022-06-06       Impact factor: 4.339

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.